Canopy Growth Corp vs Cenovus Energy Inc — how do they compare? Canopy Growth Corp trades at $1.03 (market cap $421.10M), while Cenovus Energy Inc trades at $30.13 (market cap $55.00B). The key difference: Cenovus Energy Inc is far larger — about 130.6× Canopy Growth Corp's market cap, and Cenovus Energy Inc pays a 2.09% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | CVE | |
|---|---|---|
Market Cap | $421.10M | $55.00B |
Sector | Health | Energy |
52-Week High | $1.92 | $31.80 |
52-Week Low | $0.86 | $14.83 |
Enterprise Value | $378.55M | $61.08B |
Dividend Yield | — | 2.09% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $1.02, up 7.13% with a bullish technical signal. The company reported Q1 fiscal 2027 revenue growth of 13% to C$81.2 million and narrowed its EBITDA loss. While revenue trends show stabilization after declining from $520M in 2022 to $269M in 2025, the company continues to post significant net losses with a -222.36% margin. The balance sheet shows improvement with debt-to-asset ratio declining from 53.61% in 2023 to 33.13% in 2025.
CGC presents a high-risk opportunity with potential catalysts from cannabis rescheduling and European expansion. The stock trades below book value (P/B 0.86) but faces substantial execution risks amid persistent losses. Analyst sentiment is mixed with 33% buy ratings, reflecting optimism about restructuring progress versus concerns about profitability timeline.
Cenovus Energy (CVE) trades at $30.2, up 2.17% today, with a bullish technical signal from moving averages. The company reported strong Q2 2026 earnings, matching estimates with $1.11 EPS, and raised full-year production guidance. Valuation ratios appear attractive with a P/E of 11.56 and EV/EBITDA of 5.77, while profitability remains solid with an 11.48% net income margin and 20.96% ROE.
Outlook is positive driven by higher oil prices and record oil sands production, but risks include commodity price volatility and refining margin pressures. Analyst consensus leans bullish with 11 Buy ratings, though geopolitical tensions and Canadian regulations pose headwinds for sustained growth.
Trailing returns across standard periods
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →